Search Results - "Flaker, G"

Noninvasive tissue adhesive for cardiac implantable electronic device pocket closure: the TAPE pilot study by Koerber, S. M., Loethen, T., Turagam, M., Payne, J., Weachter, R., Flaker, G., Gold, M. R., Gautam, S.

“…Purpose Device infection is a serious complication of cardiac implantable electronic devices (CIED). Ensuring complete pocket closure can be time consuming,…”
Get full text

Adverse outcomes and predictors of underuse of antithrombotic therapy in medicare beneficiaries with chronic atrial fibrillation by GAGE, B. F, BOECHLER, M, DOGGETTE, A. L, FORTUNE, G, FLAKER, G. C, RICH, M. W, RADFORD, M. J

“…Antithrombotic therapy can prevent strokes and transient ischemic attacks (TIAs) in carefully selected patients who have chronic nonvalvular atrial…”
Get full text

Ventricular Dysfunction and the Risk of Stroke after Myocardial Infarction by Loh, Evan, Sutton, Martin St. John, Wun, Chuan-Chuan C, Rouleau, Jean L, Flaker, Greg C, Gottlieb, Stephen S, Lamas, Gervasio A, Moyé, Lemuel A, Goldhaber, Samuel Z, Pfeffer, Marc A

“…Current estimates of the incidence of stroke among patients with coronary artery disease are as low as 3.4 percent per 1000 patient-years of follow-up. 1…”
Get full text

Effect of Captopril on Mortality and Morbidity in Patients with Left Ventricular Dysfunction after Myocardial Infarction: Results of the Survival and Ventricular Enlargement Trial by Pfeffer, Marc A, Braunwald, Eugene, Moyé, Lemuel A, Basta, Lofty, Brown, Edward J, Cuddy, Thomas E, Davis, Barry R, Geltman, Edward M, Goldman, Steven, Flaker, Greg C, Klein, Marc, Lamas, Gervasio A, Packer, Milton, Rouleau, Jacques, Rouleau, Jean L, Rutherford, John, Wertheimer, John H, Hawkins, C. Morton

“…SURVIVORS of acute myocardial infarction are at a greatly increased risk for subsequent fatal and nonfatal cardiovascular events. 1 This heightened risk is…”
Get full text

Inflammation, pravastatin, and the risk of coronary events after myocardial infarction in patients with average cholesterol levels by RIDKER, P. M, RIFAI, N, PFEFFER, M. A, SACKS, F. M, MOYE, L. A, GOLDMAN, S, FLAKER, G. C, BRAUNWALD, E

“…Background —We studied whether inflammation after myocardial infarction (MI) is a risk factor for recurrent coronary events and whether randomized treatment…”
Get full text

The Mode Selection Trial (MOST) in sinus node dysfunction: Design, rationale, and baseline characteristics of the first 1000 patients by Lamas, Gervasio A., Lee, Kerry, Sweeney, Michael, Leon, Angel, Yee, Raymond, Ellenbogen, Ken, Greer, Stephen, Wilber, David, Silverman, Russell, Marinchak, Roger, Bernstein, Robert, Mittleman, Robert S., Lieberman, Eric H., Sullivan, Cindi, Zorn, Lisa, Flaker, Greg, Schron, Eleanor, Orav, E.John, Goldman, Lee

“…Background More than 200,000 permanent pacemakers will be implanted in the United States in 2000 at a cost of more than $2 billion. Sick sinus syndrome (SSS)…”
Get full text

Underutilization of antithrombotic therapy in elderly rural patients with atrial fibrillation by Flaker, Greg C., McGowan, Daniel Joseph, Boechler, Michael, Fortune, Gary, Gage, Brian

“…Background Antithrombotic agents are underutilized in elderly patients with atrial fibrillation. In a peer-review audit of antithrombotic use in Missouri,…”
Get full text

Early percutaneous coronary intervention, platelet inhibition with eptifibatide, and clinical outcomes in patients with acute coronary syndromes by KLEIMAN, N. S, LINCOFF, A. M, TOPOL, E. J, CALIFF, R. M, HARRINGTON, R. A, FLAKER, G. C, PIEPER, K. S, WILCOX, R. G, BERDAN, L. G, LORENZ, T. J, COKKINOS, D. V, SIMOONS, M. L, BOERSMA, E

“…Background —Platelet glycoprotein (GP) IIb/IIIa antagonists prevent the composite end point of death or myocardial infarction (MI) in patients with acute…”
Get full text

Sphygmomanometrically determined pulse pressure is a powerful independent predictor of recurrent events after myocardial infarction in patients with impaired left ventricular function by MITCHELL, G. F, MOYE, L. A, BRAUNWALD, E, ROULEAU, J.-L, BERNSTEIN, V, GELTMAN, E. M, FLAKER, G. C, PFEFFER, M. A

“…Background There is increasing evidence of a link between conduit vessel stiffness and cardiovascular events, although the association has never been tested in…”
Get full text

Clinical significance of mitral regurgitation after acute myocardial infarction by LAMAS, G. A, MITCHELL, G. F, FLAKER, G. C, SMITH, S. C, GERSH, B. J, BASTA, L, MOYE, L, BRAUNWALD, E, PFEFFER, M. A

“…Background Mitral regurgitation (MR) may complicate acute myocardial infarction (MI). However, it is not known whether mild MR is an independent predictor of…”
Get full text

Effect of infarct artery patency on prognosis after acute myocardial infarction by LAMAS, G. A, FLAKER, G. C, SMITH, S. C, GERSH, B. J, CHUAN-CHUAN WUN, MOYE, L, ROULEAU, J. L, RUTHERFORD, J. D, PFEFFER, M. A, BRAUNWALD, E

“…Background In patients with acute myocardial infarction (MI), early restoration of patency of the infarct-related artery (IRA) leads to preservation of left…”
Get full text

Antiarrhythmic drug therapy and cardiac mortality in atrial fibrillation by Flaker, Greg C., Blackshear, Joseph L., McBride, Ruth, Kronmal, Richard A., Halperin, Jonathan L., Hart, Robert G.

“…Background and Objectives.The relation between cardiac mortality and antiarrhythmic drug administration has not been fully determined. This relation was…”
Get full text

Efficacy and Safety of Apixaban in Patients After Cardioversion for Atrial Fibrillation: Insights From the ARISTOTLE Trial (Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation) by FLAKER, Greg, LOPES, Renato D, VINEREANU, Dragos, HUSTED, Steen, HARJOLA, Veli Pekka, ROSENQVIST, Marten, ALEXANDER, John H, GRANGER, Christopher B, AL-KHATIB, Sana M, HERMOSILLO, Antonio G, HOHNLOSER, Stefan H, TINGA, Brian, JUN ZHU, MOHAN, Puneet, GARCIA, David, BARTUNEK, Jozef

“…The aim of this study was to determine the risk of major clinical and thromboembolic events after cardioversion for atrial fibrillation in subjects treated…”
Get full text

Causes of higher in-hospital mortality in women than in men after acute myocardial infarction by Jenkins, James Stephen, Flaker, Greg C., Nolte, Barbie, Price, Leigh Ann, Morris, Don, Kurz, James, Petroski, Gregory F.

“…Clinical, laboratory and cardiac catheterization parameters were reviewed in 355 men and 155 women hospitalized at a tertiary care referral center between…”
Get full text

Benefit of Oral Anticoagulant Over Antiplatelet Therapy in Atrial Fibrillation Depends on the Quality of International Normalized Ratio Control Achieved by Centers and Countries as Measured by Time in Therapeutic Range by CONNOLLY, Stuart J, POGUE, Janice, EIKELBOOM, John, FLAKER, Gregory, COMMERFORD, Patrick, GRAZIA FRANZOSI, Maria, HEALEY, Jeffrey S, YUSUF, Salim

“…Oral anticoagulation (OAC) therapy is effective in atrial fibrillation but requires vigilance to maintain the international normalized ratio in the therapeutic…”
Get full text

Pravastatin prevents clinical events in revascularized patients with average cholesterol concentrations by Flaker, Greg C., Warnica, J.Wayne, Sacks, Frank M., Moyé, Lemuel A., Davis, Barry R., Rouleau, Jean L., Webel, Richard R., Pfeffer, Marc A., Braunwald, Eugene

“…OBJECTIVES This analysis was carried out to determine if revascularized patients derive benefit from the 3-hydroxy-3 methylglutaryl coenzyme A (HMG-CoA)…”
Get full text

Cardiovascular complications of cocaine use by Goel, P, Flaker, G C

Get full text

Efficacy and Safety of Apixaban in Patients After Cardioversion for Atrial Fibrillation by Flaker, Greg, MD, Lopes, Renato D., MD, PhD, Al-Khatib, Sana M., MD, MHS, Hermosillo, Antonio G., MD, Hohnloser, Stefan H., MD, Tinga, Brian, MS, Zhu, Jun, MD, Mohan, Puneet, MD, PhD, Garcia, David, MD, Bartunek, Jozef, MD, PhD, Vinereanu, Dragos, MD, PhD, Husted, Steen, MD, DMSc, Harjola, Veli Pekka, MD, PhD, Rosenqvist, Marten, MD, Alexander, John H., MD, MHS, Granger, Christopher B., MD

“…Objectives The aim of this study was to determine the risk of major clinical and thromboembolic events after cardioversion for atrial fibrillation in subjects…”
Get full text

Angiographic predictors of reocclusion after thrombolysis: Results from the thrombolysis in myocardial infarction (TIMI) 4 trial by Gibson, C. Michael, Cannon, Christopher P., Piana, Robert N., Breall, Jeffrey A., Sharaf, Barry, Flatley, Margaret, Alexander, Barbara, Diver, Daniel J., McCabe, Carolyn H., Flaker, Greg C., Baim, Donald S., Braunwald, Eugene

“…This study attempted to determine which lesion characteristics are associated with reocclusion by 18 to 36 h. Reocclusion of the infarct-related artery after…”
Get full text

Cardiovascular Complications of Cocaine Use by Feldman, James, Auer, Johann, Berent, Robert, Eber, Bernd, Noel, Bernard, Goel, Punit, Flaker, Greg C, Lange, Richard A, Hillis, L. David

“…To the Editor: In their article on the cardiovascular complications of cocaine use, Lange and Hillis (Aug. 2 issue) 1 have not presented a balanced review of…”
Get full text